Norris Medicines informs about compliances-certificate
Norris Medicines has enclosed confirmation certificate received from Registrar and Transfer Agent ‘Purva Sharegistry (India)’ as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026.
The above information is a part of company’s filings submitted to BSE.
